Trials / Completed
CompletedNCT03566589
Effects of PS128 on Parkinsonian Symptoms
Effects of Lactobacillus Plantarum PS128 on the Parkinsonian Symptoms in Parkinson's Disease: a Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Professor Lu Neurological Clinic · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the short term effects (12 Weeks) of Lactobacillus plantarum PS128 (PS128) on Parkinson's disease (PD) symptoms.
Detailed description
This study is designed to examine the extent to which L. plantarum PS128 can improve symptoms in PD patients. L. plantarum PS128 is a psychobiotic that regulates the level of dopamine in specific brain regions. Patients with PD will receive PS128 treatment for 12 weeks. Symptoms of PD will be clinically evaluated before and after the treatment, and the results will be compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lactobacillus plantarum PS128 | daily ingestion of 60 billion colony forming unit (CFU) of Lactobacillus plantarum PS128 (30 billion CFU/capsule) |
Timeline
- Start date
- 2018-07-02
- Primary completion
- 2018-11-09
- Completion
- 2018-12-30
- First posted
- 2018-06-25
- Last updated
- 2021-03-10
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03566589. Inclusion in this directory is not an endorsement.